Brazil: Pharmacovigilance Risk in Evolving Biosimilar Regulation
Rob Rodrigues, attorney at law, had his article “Brazil: Pharmacovigilance Risk in Evolving Biosimilar Regulation” published on the FDLI – Food and Drug Law Institute website. Read it in full at: http://static.lickslegal.com/pdf/FDLI%20-%20Brazil_Pharmacovigilance_Risk_in_Evolvin%202015.pdf
RECENT PUBLICATIONS
-
The Right to in-kind compensation due to unjustified administrative delay: An approach to state civil liability on patent granting administrative proceeding
February 23, 2026 -
Acordo de proteção de dados Brasil-UE: O que muda para as empresas?
February 19, 2026 -
A indicação de Otto Lobo para a presidência da CVM
February 13, 2026